SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950137-04-006352
Filing Date
2004-08-06
Accepted
2004-08-06 16:43:21
Documents
10
Period of Report
2004-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR PERIOD ENDING 06/30/04 a00827e10vq.htm 10-Q 167057
2 EXHIBIT 10.13 a00827exv10w13.txt EX-10.13 41618
3 EXHIBIT 10.55 a00827exv10w55.txt EX-10.55 10431
4 EXHIBIT 10.56 a00827exv10w56.txt EX-10.56 12921
5 EXHIBIT 10.57 a00827exv10w57.txt EX-10.57 2656
6 EXHIBIT 10.58 a00827exv10w58.txt EX-10.58 10429
7 EXHIBIT 10.59 a00827exv10w59.txt EX-10.59 53677
8 EXHIBIT 31.1 a00827exv31w1.txt EX-31.1 3890
9 EXHIBIT 31.2 a00827exv31w2.txt EX-31.2 3922
10 EXHIBIT 32.1 a00827exv32w1.txt EX-32.1 2061
  Complete submission text file 0000950137-04-006352.txt   311258
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24274 | Film No.: 04958562
SIC: 2836 Biological Products, (No Diagnostic Substances)